Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

5.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.5K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

15.0K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
15.0K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

6.0K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
6.0K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

2.8K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.8K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

4.4K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.4K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

1.4K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Incidence, predictors and outcomes following primary graft dysfunction after cardiac transplantation.

Transplant international : official journal of the European Society for Organ Transplantation·2026
Same author

Growth patterns in patients with congenital adrenal hyperplasia analyzed by the QEPS growth model.

Frontiers in endocrinology·2026
Same author

Hypothermic oxygenated perfusion versus standard treatment of donor hearts in heart transplantation: extended follow-up of the NIHP2019 trial.

European heart journal·2026
Same author

Does donor age older or younger than 70 years influence lung transplantation outcomes?

JTCVS open·2026
Same author

External validation and updating of DIGIROP prediction models including parenteral nutrition for treatment-requiring retinopathy of prematurity in a Swedish national cohort.

BMJ open ophthalmology·2026
Same author

Low serum sphingosine-1-phospate and its chaperone ApoM associate with retinopathy of prematurity.

Journal of lipid research·2026

Related Experiment Video

Updated: Mar 31, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

1.7K

Excess Mortality among Persons with Type 2 Diabetes.

Mauro Tancredi1, Annika Rosengren, Ann-Marie Svensson

  • 1From the Department of Molecular and Clinical Medicine, University of Gothenburg (M.T., A.R., S.G., M.L.), Center of Registers in Region Västra Götaland (A.-M.S.), Statistiska Konsultgruppen (A.P.), and Nordic School of Public Health (H.W.), Gothenburg, and the Department of Medicine, NU Hospital Group, Trollhättan and Uddevalla (M.T., S.D., M.L.) - all in Sweden; Saint Luke's Mid America Heart Institute (M.K.) and Children's Mercy Hospital (M.C.), University of Missouri-Kansas City School of Medicine, Kansas City; and the University of Kansas School of Medicine, Kansas City (M.C.).

The New England Journal of Medicine
|October 29, 2015
PubMed
Summary

Mortality risk in type 2 diabetes varies significantly. Factors like age, glycemic control, and kidney complications influence outcomes, with younger patients and poorer control showing higher risks.

More Related Videos

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

1.1K
Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression
04:36

Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression

Published on: January 12, 2024

1.7K

Related Experiment Videos

Last Updated: Mar 31, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

1.7K
Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

1.1K
Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression
04:36

Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression

Published on: January 12, 2024

1.7K

Area of Science:

  • Cardiology
  • Endocrinology
  • Nephrology
  • Public Health

Background:

  • Type 2 diabetes is a global health concern with significant mortality implications.
  • Understanding the specific risks associated with glycemic control and renal complications is crucial for patient management.
  • Previous studies have not fully elucidated the excess mortality risks across different patient subgroups.

Purpose of the Study:

  • To assess the excess risks of all-cause and cardiovascular death in individuals with type 2 diabetes.
  • To examine how these risks vary based on glycemic control and the presence and severity of renal complications.
  • To compare mortality rates in type 2 diabetes patients with a matched general population cohort.

Main Methods:

  • A registry-based cohort study using the Swedish National Diabetes Register.
  • Inclusion of patients with type 2 diabetes diagnosed on or after January 1, 1998.
  • Matching each patient with five general population controls by age, sex, and county, with follow-up until December 31, 2011.

Main Results:

  • Patients with type 2 diabetes had a higher overall mortality (17.7%) compared to controls (14.5%), with an adjusted hazard ratio of 1.15.
  • Cardiovascular death rates were also elevated in the diabetes group (7.9% vs. 6.1%).
  • Excess mortality risks increased with younger age, poorer glycemic control (higher HbA1c), and more severe renal complications.

Conclusions:

  • Mortality among individuals with type 2 diabetes differs substantially from the general population.
  • Age, glycemic control, and renal complications are key determinants of mortality risk.
  • Risk stratification based on these factors is essential for personalized diabetes care and public health strategies.